← Leaderboards
Pietro Fratta
Stanford University
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,617,189 · 1
By mechanism
U54$6,617,189 · 1
Top collaborators
- Aaron D. Gitler5 shared
- Leonard Petrucelli5 shared
- Mercedes Prudencio5 shared
- Towfique Raj5 shared
- William W Seeley5 shared
Most similar at Stanford University
Same institution · by research overlap
- Aaron D. Gitler$25,518,377
- Linda C Giudice$28,525,430
- Howard Y Chang$38,678,844
- Garry P Nolan$53,568,535
- Rick Russell$6,445,536
Others in their field
Other Emerging Leaders on “Human Tissue”
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$55,356,482
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$32,915,493
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,477,162
- Hemali Phatnani · New York University School Of Medicine$22,551,091
Research focus
Human TissueNeurodegenerative DisordersHigh Resolution ImagingHuman ImagingMultimodalityNerve DegenerationGeneticGenomicsFunctional DisorderHuman GeneticsInnovationCell NucleusCodeCommunitiesBiological MarkersAddendumBiological ModelsGenetic Risk FactorBrainEventExonsHuman DiseaseBrain RegionNeurology
Grant awards (5)
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$53,900
U54 · FY2025 · NS
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,598,861
U54 · FY2024 · NS
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,597,452
U54 · FY2023 · NS
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,644,973
U54 · FY2022 · NS
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,722,003
U54 · FY2021 · NS